Covid-19: Vaccine From Bharat Biotech and AstraZeneca Oxford Approves By India

Specialists have raised worries over India’s crisis approval of a privately created Covid-19 vaccine before the completion of trials.
Delhi approved the Indian first vaccine, called “Covaxin“. Moreover, the global AstraZeneca jab being manufactured in India. (3 January 2021).

Prime Minister of India Narendra Modi called it the “Game Changer” in his recent tweet. He said it is a decisive turning point for India.
A decisive turning point to strengthen a spirited fight!
— Narendra Modi (@narendramodi) January 3, 2021
DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation.
Congratulations India.
Congratulations to our hardworking scientists and innovators.
We are not responsible for the content of external websites.
View original tweet on Twitter
It would make each Indian pleased that the two vaccines that have been given crisis use approval are made in India! This shows the enthusiasm of our academic network to satisfy the fantasy of an Aatmanirbhar Bharat, at the base of which is care and empathy. –Narendra Modi
Suggested News: The Foreign Minister Of Iran Urges Trump To Keep Away From Israel ‘trap’ To Provoke War
The Government of India said the vaccines are 100% safe, also said it might have some common sides effect as other vaccines have.
In reply to this, joy said in his tweet that it might be the best vaccine in the world but injecting publically without completing trials is not a good strategy.
Bharat Biotech’s Covaxin might turn out to be best Vaccine in world. That’s not the Point. Concern is that it has been approved without Peer Reviewed Phase 1-2 results and incomplete Phase 3 Trial. Govt saying it is 110% safe is not Data and “Give it a Chance” is not strategy
— Joy (@Joydas) January 3, 2021
We are not responsible for the content of external websites.
View original tweet on Twitter
The vaccine (Pfizer) is also seeking emergency authorization in India as it already approved for use in many countries including the U.S., U.K., and the EU.
–Bilal Asghar
One Comment